Gland Pharma Limited (GLAND) — Announcement | 22 June 2026

StockFin.ai

Try Free

📢 Key Event
Gland Pharma announces investor meeting schedule

💡 Investor Takeaway
Investors should monitor updates to the meeting schedule as changes may affect engagement timing with major funds.

Gland Pharma announced its schedule for upcoming analyst and institutional investor meetings, including one-on-one sessions with Ambit PMS arranged by B&K and 360One on June 25, 2026. The filing confirms the meeting framework but notes dates remain subject to change based on participant or company exigencies, signaling proactive engagement with key investors ahead of potential market developments.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GLAND ✨ Ask AI About This

About Gland Pharma Limited (GLAND)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹30,781.44 Cr P/E: 43.7

View full GLAND stock details →

📡 Get AI alerts when GLAND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GLAND — Free

💡 Ask AI about this filing

"How does this affect GLAND margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More GLAND filings

See all GLAND filings →

🔥 Also filed on 22 June 2026

OSWALSEEDS ShreeOswal Seeds And Chemicals Limited Announcement SOTL Savita Oil Technologies Limited Announcement ONEPOINT One Point One Solutions Limited Financial Results UEL Ujaas Energy Limited Annual Report SAREGAMA Saregama India Limited Announcement DPSCLTD DPSC Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when GLAND files new disclosures

Track GLAND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GLAND — Free

Free account · 2 AI queries/day